MétaCan
Menu
Back to cohort
Record W3195505129 · doi:10.1186/s13063-021-05489-x

The role of machine learning in clinical research: transforming the future of evidence generation

2021· review· en· W3195505129 on OpenAlexaff
E. Hope Weissler, Tristan Naumann, Tomas Andersson, Rajesh Ranganath, Olivier Elemento, Yuan Luo, Daniel F. Freitag, James Benoit, Michael C. Hughes, Faisal M. Khan, Paul Slater, Khader Shameer, Matthew T. Roe, Emmette R. Hutchison, Scott H. Kollins, Uli C. Broedl, Zhaoling Meng, Jennifer Wong, Lesley H. Curtis, Erich Huang, Marzyeh Ghassemi

Bibliographic record

VenueTrials · 2021
Typereview
Languageen
FieldMedicine
TopicArtificial Intelligence in Healthcare and Education
Canadian institutionsUniversity of TorontoVector InstituteBoehringer Ingelheim (Canada)University of Alberta
FundersMinistry of Science, ICT and Future PlanningDuke Clinical Research InstituteNovo NordiskVerily Life SciencesJanssen PharmaceuticalsMyoKardiaRegeneron PharmaceuticalsBayerEli Lilly and CompanyAstraZenecaPfizerAmgenMicrosoftPatient-Centered Outcomes Research InstituteCytokineticsSanofiJanssen BiotechAmerican Heart Association
KeywordsClinical trialMedicineStakeholderClinical researchData collectionAnalyticsKnowledge managementPublic relationsData sciencePathologyPolitical scienceComputer science

Abstract

fetched live from OpenAlex

BACKGROUND: Interest in the application of machine learning (ML) to the design, conduct, and analysis of clinical trials has grown, but the evidence base for such applications has not been surveyed. This manuscript reviews the proceedings of a multi-stakeholder conference to discuss the current and future state of ML for clinical research. Key areas of clinical trial methodology in which ML holds particular promise and priority areas for further investigation are presented alongside a narrative review of evidence supporting the use of ML across the clinical trial spectrum. RESULTS: Conference attendees included stakeholders, such as biomedical and ML researchers, representatives from the US Food and Drug Administration (FDA), artificial intelligence technology and data analytics companies, non-profit organizations, patient advocacy groups, and pharmaceutical companies. ML contributions to clinical research were highlighted in the pre-trial phase, cohort selection and participant management, and data collection and analysis. A particular focus was paid to the operational and philosophical barriers to ML in clinical research. Peer-reviewed evidence was noted to be lacking in several areas. CONCLUSIONS: ML holds great promise for improving the efficiency and quality of clinical research, but substantial barriers remain, the surmounting of which will require addressing significant gaps in evidence.

Fetched live from OpenAlex and de-inverted. Abstracts are not stored in this database: the inverted indexes are 8.6 GB of the frame’s 9.3 GB of text, and the host has 13 GB free.

How this classification was reachedexpand

Full frame machine prediction

Teacher imitation

Not calibrated prevalence, not ground truth. Human validation pending. The Gemma side is a direct model label for every work in the frame, read from the title-only record. The Codex side is a classifier learned from the 10,348 direct Codex labels and calibrated to design-weighted sample rates; fields without enough sample support carry no Codex call. Candidate is the union of the two sides; consensus is their intersection. These outputs are machine_predicted_unvalidated and are not human labels.

metaresearch head score (Codex)0.101
metaresearch head score (Gemma)0.170
Version: metacan-v3-hybrid-931329e0061cValidation status: machine_predicted_unvalidated
Candidate categoriesMetaresearch
Consensus categoriesnone
DomainCandidate signal: Methods · Consensus signal: none
Study designCandidate signal: Theoretical or conceptual · Consensus signal: none
GenreCandidate signal: Review · Consensus signal: Review
Teacher disagreement score0.899
Threshold uncertainty score0.533

Distilled classifier scores by category (both heads)

CategoryCodexGemma
Metaresearch0.1010.170
Meta-epidemiology (narrow)0.0010.001
Meta-epidemiology (broad)0.0040.003
Bibliometrics0.0080.007
Science and technology studies0.0010.007
Scholarly communication0.0090.012
Open science0.0030.005
Research integrity0.0070.011
Insufficient payload (model declined to judge)0.0030.001

Machine scores (provisional)

The two teacher heads of the student model, read on this work. A score orders the frame for review; it never asserts a category, and the validation status ships verbatim with every row.

Baseline scores from an immature model (maturity gate not passed, 7 training rounds). Scores rank; they never assert a category.

Opus teacher head0.928
GPT teacher head0.704
Teacher spread0.224 · how far apart the two teachers sit on this one work
Validation statusscore_only:v0-immature-baseline · verbatim from the scoring run: score_only means the number may rank works, and no category label ships from it

Classification

machine, unvalidated

Machine predicted; a candidate call from one source (direct Gemma or distilled Codex), not a consensus.

Study designTheoretical or conceptual
DomainMethods
GenreReview

How this classification was reached, model by model and score by score, is at the end of the page under "How this classification was reached".

Quick stats

Citations282
Published2021
Admission routes1
Has abstractyes

Explore more

Same venueTrialsSame topicArtificial Intelligence in Healthcare and EducationFrench-language works237,207